Acetazolamide
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Acetazolamide. Acetazolamide is a carbonic anhydrase inhibitor. Fully referenced neurology checklist.
Mode of action
- Acetazolamide is a carbonic anhydrase inhibitor
- It acts on hyperpolarization-activated cyclic nucleotide-gated (HCN) channels
- It is used as adjunct or monotherapy
Indications
Locked: subscribe to see this section.
Dosing
Locked: subscribe to see this section.
Side effects
Locked: subscribe to see this section.
References
- Reiss WG, Oles KS. Acetazolamide in the treatment of seizures. Ann Pharmacother 1996; 30:514-519.
- Vrielynck P. Current and emerging treatments for absence seizures in young patients. Neuropsychiatr Dis Treat 2013; 9:963-975.
- Resor SR Jr, Resor LD. Chronic acetazolamide monotherapy in the treatment of juvenile myoclonic epilepsy. Neurology 1990; 40:1677-1681.
- Hoddevik GH. Acetazolamide-are there reasons for its revival in antiepileptic treatment? Tidsskr Nor Laegeforen 2000; 120:1042-1045.
- Vaamonde J, Legarda I, Jimenez-Jimenez J, Obeso JA. Acetazolamide improves action myoclonus in Ramsay Hunt syndrome. Clin Neuropharmacol 1992; 15:392-396.
- And 4 more. Subscribe to see the full list